Domestic News: New Products, Technological Innovations, Business Strategies
1. Canon Launches "Ultimion," Japan's First Domestically Produced Photon-Counting CT
News Highlights
Canon Medical Systems Corporation announced that it will commence domestic sales of "Ultimion," Japan's first domestically produced photon-counting CT (PCCT), a next-generation X-ray CT attracting significant attention, on April 17, 2026.
Impact on the Industry
By adopting a photon-counting detector, which differs from conventional CTs, Ultimion can provide high-resolution images and advanced spectral images. This is expected to further improve diagnostic accuracy and significantly reduce radiation exposure. Furthermore, with the integration of "INSTINX," an AI-powered automation technology, it is garnering attention as a groundbreaking product that will greatly contribute to the efficiency of workflows in medical settings.
2. Nichiban Launches Limited Sales of "BreathScan™," a Wearable Device for Visualizing Respiratory Motion
News Highlights
Nichiban Corporation, in collaboration with Saintol Corporation, began limited sales of "BreathScan™" (a general medical device), an adhesive wearable device that visualizes respiratory motion simply by attaching it to the chest, to medical institutions in April 2026.
Impact on the Industry
It is expected to become widespread as a simple screening tool for lung diseases, such as chronic obstructive pulmonary disease (COPD), whose early symptoms are often overlooked. As it does not require bulky equipment and utilizes Nichiban's strength in "skin-friendly adhesives," it contributes to reducing the burden on both patients and healthcare professionals. This marks an important step towards mass production and sales in the latter half of fiscal year 2026.
3. Terumo Significantly Expands R&D and Manufacturing Bases in Costa Rica
News Highlights
Terumo Corporation, a major medical device company, is proceeding with the construction of large-scale manufacturing and research and development (R&D) bases in Costa Rica, Central America. Since its full-scale entry in 2013, investments have reached several hundred million dollars, and employment has expanded to approximately 3,300 people.
Impact on the Industry
Costa Rica, also known as the “Silicon Valley of medical devices,” plays a crucial role as a shipping base to the vast U.S. market. This strategic establishment of bases is aimed at diversifying U.S. tariff policies and geopolitical risks, and it can be considered a representative success story of Japanese medical device manufacturers optimizing their global supply chains.
International News: Regulatory Trends, M&A, Market Environment
1. FDA Rejects Proposal for Deregulation of AI Medical Devices
News Highlights
The U.S. Food and Drug Administration (FDA) rejected a proposal from the industry for deregulation concerning certain AI (Artificial Intelligence) medical devices.
Impact on the Industry
While significant deregulation in the medical AI sector was anticipated under the Trump administration, the FDA has prioritized ensuring safety and efficacy, clearly indicating its stance to maintain a certain regulatory framework. Companies developing AI-powered Software as a Medical Device (SaMD) will continue to be required to address stringent clinical evaluations and approval processes.
2. FDA and Medical Device Industry Reach General Agreement on MDUFA VI (Medical Device User Fee Act)
News Highlights
The FDA and the medical device industry have reached a "general agreement" on the framework for the next Medical Device User Fee Act (MDUFA VI), which will apply from 2027 to 2032.
Impact on the Industry
This agreement includes continued funding for a "significant increase" in review staff at the FDA's Center for Devices and Radiological Health (CDRH). CDRH had faced staffing shortages due to large-scale personnel reductions implemented by the U.S. Department of Health and Human Services (HHS) last year. This agreement is expected to rebuild the review system and stabilize the process for bringing new products to market.
3. Impact of U.S. Tariff Policies on Medtech Companies and Their Responses
News Highlights
In response to new tariff policies by the Trump administration, U.S. medtech (medical technology) companies are working to absorb the impact through organization-wide cost reductions and supply chain optimization, while avoiding price pass-throughs and reductions in research and development (R&D) spending.
Impact on the Industry
Some major companies estimate that the impact of tariffs on revenue could range from $200 million to $500 million annually. However, the industry as a whole maintains resilience, and strategic responses such as optimizing logistics and securing alternative suppliers are clearly demonstrating a commitment to maintaining long-term growth foundations.
4. Boston Scientific Completes Acquisition of Valencia Technologies
News Highlights
Leading medical device manufacturer Boston Scientific has completed the acquisition of Valencia Technologies, a developer of urinary incontinence treatment devices.
Impact on the Industry
Valencia Technologies develops "eCoin," a tibial nerve stimulation device for treating urge urinary incontinence associated with overactive bladder. This acquisition will further expand Boston Scientific's product portfolio in the urology sector, significantly strengthening its competitiveness in this market.
Summary: Key Industry Trends
From today's news, it is evident that the medical device industry is currently moving along the following three major trends:
- Clinical Implementation of Advanced Technologies (AI, Next-Generation Sensors) (e.g., Canon's PCCT, Nichiban's wearable devices)
- Reconstruction of Global Supply Chains and Risk Management (e.g., Terumo's Costa Rica facility expansion, US tariff responses)
- Strengthening Regulatory Bodies and Ensuring Safety (e.g., MDUFA VI agreement, maintaining AI medical device regulations)
Particularly impressive is the strong presence of Japanese medical device manufacturers in the global market, leveraging their high technological capabilities, as seen in the launch of the first domestically produced next-generation CT and the expansion of Japanese companies' overseas bases.
Related Links
- Canon Medical Systems: Launch of "Ultimion", Japan's first photon-counting CT
- Nichiban Co., Ltd.: Limited release of "Breathscan™", a wearable patch device that visualizes respiratory movement by simply attaching it to the chest
- Nikkei: "Medical Device Silicon Valley" Costa Rica to create 3,000 R&D jobs
- STAT News: FDA rejects an industry proposal to deregulate some AI devices
- MedTech Dive: FDA, medtech industry near MDUFA VI agreement
- MedTech Dive: One year in: How medtech companies are coping with tariff challenges
- MedTech Dive: Boston Scientific closes buyout of Valencia Technologies
Need help with Japan's medical device approval?
Our regulatory affairs consultants specializing in digestive endoscopy devices provide end-to-end support from strategy to document preparation. Contact us for a free initial consultation.
Free Consultation